Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II study

Smyth, L. M.; Iyengar, N. M.; Chen, M. F.; Popper, S. M.; Patil, S.; Wasserheit-Lieblich, C.; Argolo, D. F.; Singh, J. C.; Chandarlapaty, S.; Sugarman, S. M.; Comen, E. A.; Drullinsky, P. R.; Traina, T. A.; Troso-Sandoval, T.; Baselga, J.; Norton, L.; Hudis, C. A.; Dang, C. T.

期刊名称Breast Cancer Research and Treatment
作者Smyth, L. M.; Iyengar, N. M.; Chen, M. F.; Popper, S. M.; Patil, S.; Wasserheit-Lieblich, C.; Argolo, D. F.; Singh, J. C.; Chandarlapaty, S.; Sugarman, S. M.; Comen, E. A.; Drullinsky, P. R.; Traina, T. A.; Troso-Sandoval, T.; Baselga, J.; Norton, L.; Hudis, C. A.; Dang, C. T.
卷第158卷
期第1期
印刷ISSN0167-6806
电子ISSN1573-7217
文件大小794.42KB
发表时间2016-7
DOI10.1007/s10549-016-3851-7
页码91-97

发现好书期刊，享受阅读乐趣

Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II study